Quick Takeaways
- PRICE T ROWE ASSOCIATES INC /MD/ filed SCHEDULE 13G/A for KESTRA MEDICAL TECHNOLOGIES COMMON STOCK (KMTS).
- Disclosed ownership: 10%.
- Date of event: 31 Mar 2026.
PRICE T ROWE ASSOCIATES INC /MD/ - 31 Mar 2026 SCHEDULE 13G/A Report for KESTRA MEDICAL TECHNOLOGIES COMMON STOCK (KMTS)
- Filing Manager
- PRICE T ROWE ASSOCIATES INC /MD/
- Reporting Manager
- T. Rowe Price Associates, Inc.
- Symbol
- KMTS
- Shares outstanding
- 58,516,314 shares
- Disclosed Ownership
- 5,968,664 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 08 Apr 2026, 15:25:24 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"PRICE T ROWE ASSOCIATES INC /MD/ disclosed 10% ownership in KESTRA MEDICAL TECHNOLOGIES COMMON STOCK (KMTS) on 31 Mar 2026."
What Changed
- Previous schedule filing date: 17 Feb 2026.
- Current filing was accepted on 08 Apr 2026, 15:25.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Associates, Inc. | 10% | 5,968,664 | 5,966,639 | 0 | Ellen York | Vice President |